Towards that end, the European Society for Medical Oncology (ESMO) has developed a new guidance document that outlines the ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback